Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019

[1]  K. McVary,et al.  The rising worldwide impact of benign prostatic hyperplasia , 2020, BJU international.

[2]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[3]  Z. Tandoğdu,et al.  Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: A Bayesian analytical approach applied in a surveillance study , 2019, PloS one.

[4]  M. Molokhia,et al.  Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study , 2019, BMJ.

[5]  Lisa E. Vaughan,et al.  Risk of ESRD and Mortality in Kidney and Bladder Stone Formers. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  K. Ahmed,et al.  Evolution and Uptake of the Endoscopic Stone Treatment Step 1 (EST-s1) Protocol: Establishment, Validation, and Assessment in a Collaboration by the European School of Urology and the Uro-Technology and Urolithiasis Sections. , 2018, European urology.

[7]  Z. Tandoğdu,et al.  Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[8]  Shaun Wen Huey Lee,et al.  The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis , 2017, Scientific Reports.

[9]  Y. Lotan,et al.  Epidemiology of stone disease across the world , 2017, World Journal of Urology.

[10]  K. Ghani,et al.  Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs. , 2017, European urology focus.

[11]  Yan-xin Wang,et al.  Major geogenic factors controlling geographical clustering of urolithiasis in China. , 2016, The Science of the total environment.

[12]  K. B. Egan,et al.  The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. , 2016, The Urologic clinics of North America.

[13]  D. Goldfarb,et al.  Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[14]  A. Babiker,et al.  Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012 , 2016, Antimicrobial Agents and Chemotherapy.

[15]  S. Hultgren,et al.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options , 2015, Nature Reviews Microbiology.

[16]  D. Paterson,et al.  Multidrug-resistant Escherichia coli in Asia: epidemiology and management , 2015, Expert review of anti-infective therapy.

[17]  R. Kirby,et al.  Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) – focus on the UK , 2015, BJU international.

[18]  P Howard,et al.  An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. , 2014, The Journal of antimicrobial chemotherapy.

[19]  M. Menon,et al.  Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges. , 2014, The Journal of urology.

[20]  Z. Tandoğdu,et al.  Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010 , 2014, World Journal of Urology.

[21]  S. Bariol,et al.  Changes in upper urinary tract stone composition in Australia over the past 30 years , 2013, BJU international.

[22]  V. Walker,et al.  Demography and biochemistry of 2800 patients from a renal stones clinic , 2013, Annals of clinical biochemistry.

[23]  Chun-Eng Liu,et al.  Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). , 2012, International journal of antimicrobial agents.

[24]  J. Pitout.  Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance , 2012, Front. Microbio..

[25]  G. Kahlmeter,et al.  Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. , 2012, International journal of antimicrobial agents.

[26]  Y. Carmeli,et al.  Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. , 2011, The Journal of infection.

[27]  J. Marshall,et al.  Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: A systematic review and meta-analysis of observational studies , 2011, Critical care medicine.

[28]  A. Schaeffer,et al.  Urinary tract infections in women. , 2011, The Medical clinics of North America.

[29]  F. Sánchez-Martín,et al.  [Incidence and prevalence of published studies about urolithiasis in Spain. A review]. , 2007, Actas urologicas espanolas.

[30]  J. Lieske,et al.  Renal stone epidemiology in Rochester, Minnesota: an update. , 2006, Kidney international.

[31]  E. Feuer,et al.  Partitioning linear trends in age-adjusted rates , 2004, Cancer Causes & Control.

[32]  C. Brun-Buisson,et al.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units , 2004, Intensive Care Medicine.

[33]  Betsy Foxman,et al.  Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. , 2003, Infectious disease clinics of North America.

[34]  T. Hooton.  Pathogenesis of urinary tract infections: an update. , 2000, The Journal of antimicrobial chemotherapy.

[35]  Hooton.  Pathogenesis of urinary tract infections: an update. , 2000, The Journal of antimicrobial chemotherapy.

[36]  W. Stamm,et al.  Urinary tract infection , 2010 .